ClinicalTrials.gg
RecruitingNCT07856927Updated Oct 5, 2026

To Share or Not To Share: Navigating Disclosure and Stigma Among Family Caregivers of Autistic Young Adults_Group Intervention

An interventional study of Group Intervention in Autism, sponsored by University of Wisconsin, Madison. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Oct 5, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 604 studies in Autistic Disorder with a site in United States — 123 open to participants now, 152 under way, 3 of them phase 3. Autistic Disorder · United States.

Planned enrollment
218th of 505
50 · median 44
Started
2026
with 46 others
No phase
296 of 604
83 open now
Primary completion
2027-06
later than 64 of 150 live
Registered
601st of 604
by date

Among the 604 studies in Autistic Disorder with a site in United States, this one is the 218th largest by planned enrollment of the 505 interventional ones that give a count, is one of 47 that started in 2026, is one of 296 with no phase, reaches primary completion later than 64 of the 150 other live ones, and was the 601st registered.

Autistic Disorder

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

123 of the 604 studies in Autistic Disorder with a site in United States are open now. Recruiting first, the newest first:

117 more — sign in →

All 123 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 604 studies in Autistic Disorder with a site in United States, or all of them as a file.
02

Study summary

This study is a caregiver support program for family caregivers of autistic young adults (ages 18 to 26) as their family members navigate young adulthood. The program includes six 60-minute virtual sessions focused on making sense of caregiving roles during young adulthood, reflecting on everyday family experiences, supporting decision-making within families, deciding when and how to share experiences with others, and thinking about the future.

Read the detailed description

This program has three components:

  1. program participation, which includes six virtual sessions and one optional celebration session
  2. eight surveys, including one pre-program survey, one post-program survey, and six post-session surveys to collect participants feedback on each session; and
  3. one optional one-on-one interview.

For the six sessions, this program utilizes a peer-facilitated model, recognizing the unique expertise that comes from lived experience. Some aspects of navigating transition can only be fully understood and effectively communicated by fellow family caregivers, rather than by professionals.

Attendees are encouraged to bring their broader life experiences, including those unrelated to caregiving, when they see these experiences as central to who they are. The program welcomes participants as whole people, honoring both their caregiving role and the parts of their lives that extend beyond it.

Session content and topics are built from a series of interviews with family caregivers. The program not only covers what was openly discussed in those interviews but also explores what was less visible, what may have been unspoken, hidden, or missing from the conversations.

03

Conditions studied

  • Autism

Browse trials for

Keywords

  • caregiver support
  • young adulthood
  • well-being
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Has a family member aged 18-26 who has received an autism-related diagnosis from a healthcare professional
  • Must be a primary caregiver for this family member
  • Must be able to speak, understand, and read English well
  • Participants will be able to provide consent themselves.

Exclusion criteria

Exclusion Criteria:

  • Lack of proficiency in English
  • Not a primary caregiver for a family member with autism aged 18-26
  • Individuals requiring a guardian to provide consent will be excluded
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Family Caregivers

    Family Caregivers of Autistic Young Adults

    Other: Group Intervention

Interventions

  • OtherGroup Intervention

    Six 60-min virtual sessions Surveys before and after program intervention Optional post-intervention interview

    Also known as: Anchors and Sails

06

What researchers measure

Primary outcomes

  1. Devaluation of Consumer Families (DCFS) Scale

    9-items scored on a 4 point likert scale from 1 (strongly disagree) to 4 (strongly agree). Total range of scores is 9-36 with higher scores indicating higher devaluation of the family.

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

  2. Self-Compassion Scale Score

    Self-Compassion Scale (26-item), scored from 26 to 130, with higher scores indicating greater self-compassion.

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

  3. Caregiving Appraisal Scale Score: Agreement

    Caregiving Appraisal Scale (6-item) scored from 6-30 where higher scores indicate higher appraisal.

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

  4. Caregiving Appraisal Scale Score: Frequency

    Caregiving Appraisal Scale (23-item) scored from 23-115 where higher scores indicate more frequency of appraisal.

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

Secondary outcomes

  1. Family Empowerment Scale Score

    Family Empowerment Scale (12-item) scored from 12-60 with higher scores meaning more empowered.

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

  2. State Hope Scale Score

    State Hope Scale (6-item) scored from 6-48 where higher scores indicate more hope

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

  3. Caregiving Confidence Scale (CSES-8) Score

    CSES-8 scored from 1-10 with higher scores meaning more confidence

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

  4. Affiliate Stigma Scale Score

    Affiliate Stigma Scale (22-item) scored from 22-88 where higher scores indicate increased stigma

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

  5. Caregiving Flexibility Score

    Caregiving flexibility score (18-item) scored from 18-72 where higher scores indicate increased flexibility

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

  6. Feeling of Loneliness Score

    Feeling of Loneliness (3-item) scored from 3-9 where higher scores indicate increased loneliness

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

  7. Autonomy Support Scale Score

    Autonomy Support Scale (5-item) scored from 5-20 where higher scores indicate more autonomy

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

  8. Emotional Support Scale Score

    Emotional Support Scale (6-item) scored from 6-30 where higher scores indicate increased emotional support

    Time frame: baseline (pre-intervention) and 6 weeks (post-intervention)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Jun 2027, 9 months after the start.

Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 9 months is below that.

Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2026
First posted
Oct 5, 2026
StartActual
Sep 17, 2026
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2027
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07856927
Responsible party
Sponsor
First posted
Oct 5, 2026
Start date
Sep 17, 2026
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Oct 5, 2026

Study contacts

Sang Qin, PhD
Contact
sqin38@wisc.edu
Sang Qin, PhD
principal investigator · University of Wisconsin, Madison

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion